# Innventure, Inc.: financial statements, quarterly

INV · Nasdaq · CIK 2001557 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inv.md) · [Financials](/companies/inv/financials.md) · [Filings](/companies/inv/filings.md) · [Insiders](/companies/inv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inv/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.3](/filings/0001628280-24-047822.md) | [0.2 d](/filings/0001628280-25-017614.md) | [0.2](/filings/0001628280-25-025892.md) | [0.2](/filings/0001628280-25-040379.md) | [0.3](/filings/0001628280-25-052035.md) | [0.5](/filings/0002001557-26-000060.md) | [0.2](/filings/0002001557-26-000115.md) | [0.5](/filings/0002001557-26-000154.md) | [0.5](/filings/0001628280-25-052035.md) | [0.8 d](/filings/0002001557-26-000060.md) | [1.4](/filings/0002001557-26-000115.md) | [1.0](/filings/0002001557-26-000154.md) |
| Cost of revenue | $m | [0.0](/filings/0001628280-24-047822.md) | [0.0 d](/filings/0001628280-25-017614.md) | [0.0](/filings/0001628280-25-025892.md) | [0.0](/filings/0001628280-25-040379.md) | [0.8](/filings/0001628280-25-052035.md) | [3.8](/filings/0002001557-26-000060.md) | [0.2](/filings/0002001557-26-000115.md) | [2.9](/filings/0002001557-26-000154.md) | [4.1](/filings/0001628280-25-052035.md) | [11.6 d](/filings/0002001557-26-000060.md) | [5.3](/filings/0002001557-26-000115.md) | [5.1](/filings/0002001557-26-000154.md) |
| Research and development | $m | [1.2](/filings/0001628280-24-047822.md) | [1.2 d](/filings/0001628280-25-017614.md) | [1.7](/filings/0001628280-25-025892.md) | [1.8](/filings/0001628280-25-040379.md) | [2.5](/filings/0001628280-25-052035.md) | [5.3](/filings/0002001557-26-000060.md) | [6.3](/filings/0002001557-26-000115.md) | [6.1](/filings/0002001557-26-000154.md) | [6.2](/filings/0001628280-25-052035.md) | [6.6 d](/filings/0002001557-26-000060.md) | [7.8](/filings/0002001557-26-000115.md) | [9.8](/filings/0002001557-26-000154.md) |
| Operating income | $m | [(5.7)](/filings/0001628280-24-047822.md) | [(10.0) d](/filings/0001628280-25-017614.md) | [(10.5)](/filings/0001628280-25-025892.md) | [(11.3)](/filings/0001628280-25-040379.md) | [(13.7)](/filings/0001628280-25-052035.md) | [(40.3)](/filings/0002001557-26-000060.md) | [(261)](/filings/0002001557-26-000115.md) | [(143)](/filings/0002001557-26-000154.md) | [(29.2)](/filings/0001628280-25-052035.md) | [(31.7) d](/filings/0002001557-26-000060.md) | [(27.3)](/filings/0002001557-26-000115.md) | [(31.5)](/filings/0002001557-26-000154.md) |
| Interest expense | $m | [0.4](/filings/0001628280-24-047822.md) | [0.5 d](/filings/0001628280-25-017614.md) | [0.5](/filings/0001628280-25-025892.md) | [0.1](/filings/0001628280-25-040379.md) | [1.0](/filings/0001628280-25-052035.md) | [1.3](/filings/0002001557-26-000060.md) | [1.8](/filings/0002001557-26-000115.md) | [2.9](/filings/0002001557-26-000154.md) | [3.5](/filings/0001628280-25-052035.md) | [2.3 d](/filings/0002001557-26-000060.md) | [1.5](/filings/0002001557-26-000115.md) | [1.1](/filings/0002001557-26-000154.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-047822.md) | [0.0 d](/filings/0001628280-25-017614.md) | [0.0](/filings/0001628280-25-025892.md) | [0.0](/filings/0001628280-25-040379.md) | [0.0](/filings/0001628280-25-052035.md) | [(3.3)](/filings/0002001557-26-000060.md) | [(1.4)](/filings/0002001557-26-000115.md) | [(2.2)](/filings/0002001557-26-000154.md) | [(3.6)](/filings/0001628280-25-052035.md) | [(6.3) d](/filings/0002001557-26-000060.md) | [(3.0)](/filings/0002001557-26-000115.md) | [(1.5)](/filings/0002001557-26-000154.md) |
| Net income | $m | [(18.9)](/filings/0001628280-24-047822.md) | [(13.0) d](/filings/0001628280-25-017614.md) | [(5.2)](/filings/0001628280-25-025892.md) | [(7.3)](/filings/0001628280-25-040379.md) | [(2.2)](/filings/0001628280-25-052035.md) | [(61.8)](/filings/0002001557-26-000060.md) | [(143)](/filings/0002001557-26-000115.md) | [(84.2)](/filings/0002001557-26-000154.md) | [(28.3)](/filings/0001628280-25-052035.md) | [(37.8) d](/filings/0002001557-26-000060.md) | [(20.8)](/filings/0002001557-26-000115.md) | [(26.5)](/filings/0002001557-26-000154.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.94)](/filings/0001628280-25-052035.md) | [(1.41)](/filings/0002001557-26-000060.md) | [(3.10)](/filings/0002001557-26-000115.md) | [(1.60)](/filings/0002001557-26-000154.md) | [(0.51)](/filings/0001628280-25-052035.md) | not reported | [(0.27)](/filings/0002001557-26-000115.md) | [(0.32)](/filings/0002001557-26-000154.md) |
| Basic EPS | $ per share | [(0.84)](/filings/0001628280-24-047822.md) | not reported | not reported | not reported | [(0.94)](/filings/0001628280-25-052035.md) | [(1.41)](/filings/0002001557-26-000060.md) | [(3.10)](/filings/0002001557-26-000115.md) | [(1.60)](/filings/0002001557-26-000154.md) | [(0.51)](/filings/0001628280-25-052035.md) | not reported | [(0.27)](/filings/0002001557-26-000115.md) | [(0.32)](/filings/0002001557-26-000154.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [11.1](/filings/0002001557-26-000060.md) | not reported | [7.0](/filings/0001628280-25-040379.md) | [9.1](/filings/0001628280-25-052035.md) | [60.4](/filings/0002001557-26-000154.md) | [55.4](/filings/0002001557-26-000115.md) | [41.5](/filings/0002001557-26-000154.md) |
| Current assets | $m | not reported | [5.7](/filings/0001628280-25-017614.md) | not reported | not reported | [21.2](/filings/0001628280-24-047822.md) | [24.3](/filings/0002001557-26-000060.md) | [10.3](/filings/0001628280-25-025892.md) | [21.1](/filings/0001628280-25-040379.md) | [32.3](/filings/0001628280-25-052035.md) | [83.2](/filings/0002001557-26-000154.md) | [81.8](/filings/0002001557-26-000115.md) | [71.4](/filings/0002001557-26-000154.md) |
| Total assets | $m | not reported | [21.6](/filings/0001628280-25-017614.md) | not reported | not reported | [55.7](/filings/0001628280-24-047822.md) | [905](/filings/0002001557-26-000060.md) | [660](/filings/0001628280-25-025892.md) | [556](/filings/0001628280-25-040379.md) | [557](/filings/0001628280-25-052035.md) | [599](/filings/0002001557-26-000154.md) | [591](/filings/0002001557-26-000115.md) | [575](/filings/0002001557-26-000154.md) |
| Current liabilities | $m | not reported | [8.2](/filings/0001628280-25-017614.md) | not reported | not reported | [41.6](/filings/0001628280-24-047822.md) | [69.3](/filings/0002001557-26-000060.md) | [47.3](/filings/0001628280-25-025892.md) | [72.3](/filings/0001628280-25-040379.md) | [82.5](/filings/0001628280-25-052035.md) | [76.3](/filings/0002001557-26-000154.md) | [59.8](/filings/0002001557-26-000115.md) | [59.8](/filings/0002001557-26-000154.md) |
| Total liabilities | $m | not reported | [29.4](/filings/0001628280-25-017614.md) | not reported | not reported | [55.5](/filings/0001628280-24-047822.md) | [139](/filings/0002001557-26-000060.md) | [106](/filings/0001628280-25-025892.md) | [130](/filings/0001628280-25-040379.md) | [150](/filings/0001628280-25-052035.md) | [116](/filings/0002001557-26-000154.md) | [93.3](/filings/0002001557-26-000115.md) | [91.9](/filings/0002001557-26-000154.md) |
| Long-term debt | $m | not reported | [5.5](/filings/0001628280-25-017614.md) | not reported | not reported | [0.3](/filings/0001628280-24-047822.md) | [13.7](/filings/0002001557-26-000060.md) | [12.3](/filings/0001628280-25-025892.md) | [16.8](/filings/0001628280-25-040379.md) | [29.5](/filings/0001628280-25-052035.md) | [8.3](/filings/0002001557-26-000154.md) | [6.9](/filings/0002001557-26-000115.md) | [5.9](/filings/0002001557-26-000154.md) |
| Shareholders' equity | $m | [(18.0)](/filings/0001628280-24-047822.md) | [(20.0)](/filings/0001628280-25-017614.md) | [(10.5)](/filings/0001628280-25-052035.md) | [(11.7)](/filings/0001628280-25-052035.md) | [(22.3)](/filings/0001628280-25-052035.md) | [426](/filings/0002001557-26-000060.md) | [261](/filings/0001628280-25-025892.md) | [219](/filings/0001628280-25-040379.md) | [191](/filings/0001628280-25-052035.md) | [204](/filings/0002001557-26-000154.md) | [223](/filings/0002001557-26-000115.md) | [213](/filings/0002001557-26-000154.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.3) d](/filings/0001628280-25-017614.md) | [(7.4)](/filings/0001628280-25-025892.md) | [(9.0) d](/filings/0001628280-25-040379.md) | [(2.3) d](/filings/0001628280-25-052035.md) | [(29.2)](/filings/0002001557-26-000060.md) | [(14.7)](/filings/0002001557-26-000115.md) | [(22.1) d](/filings/0002001557-26-000154.md) | [(19.6) d](/filings/0001628280-25-052035.md) | [(24.4) d](/filings/0002001557-26-000060.md) | [(34.0)](/filings/0002001557-26-000115.md) | [(25.4) d](/filings/0002001557-26-000154.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001628280-25-017614.md) | [0.6](/filings/0001628280-25-025892.md) | [0.1 d](/filings/0001628280-25-040379.md) | [0.0 d](/filings/0001628280-25-052035.md) | [0.3](/filings/0002001557-26-000060.md) | [0.9](/filings/0002001557-26-000115.md) | [0.0 d](/filings/0002001557-26-000154.md) | [0.4 d](/filings/0001628280-25-052035.md) | [0.0 d](/filings/0002001557-26-000060.md) | [0.8](/filings/0002001557-26-000115.md) | [0.2 d](/filings/0002001557-26-000154.md) |
| Dividends paid | $m | not reported | [0.0](/filings/0001628280-25-025892.md) | not reported | not reported | [0.7](/filings/0001628280-25-017614.md) | [0.0](/filings/0001628280-25-025892.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.9](/filings/0001628280-25-052035.md) | [44.0](/filings/0002001557-26-000060.md) | [46.3](/filings/0002001557-26-000115.md) | [52.5](/filings/0002001557-26-000154.md) | [55.8](/filings/0001628280-25-052035.md) | [77.8](/filings/0002001557-26-000115.md) | [83.1](/filings/0002001557-26-000154.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 84,612,657 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0002001557-26-000154.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.